US 11208456
Anti-KRAS-G12D T cell receptors
granted A61KA61K38/00A61P
Quick answer
US patent 11208456 (Anti-KRAS-G12D T cell receptors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K38/00, A61P, A61P35/00